Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Bitopertin

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Rejects Disc’s Rare Blood Disease Drug Amid Reports of Prasad
    FDA Rejects Disc’s Rare Blood Disease Drug Amid Reports of Prasad

    17 Feb 2026

    // BIOSPACE

    https://www.biospace.com/fda/fda-rejects-discs-rare-blood-disease-drug-amid-reports-of-prasads-skepticism

    BIOSPACE
    17 Feb 2026
    Share Share
    Disc's Rare Disease Drug Hit By FDA Rejection
    Disc's Rare Disease Drug Hit By FDA Rejection

    14 Feb 2026

    // PRESS RELEASE

    https://ir.discmedicine.com/news-releases/news-release-details/disc-medicine-receives-complete-response-letter-fda-bitopertin

    PRESS RELEASE
    14 Feb 2026
    Share Share
    Disc Medicine Showcases 2026 Achievements And Business Goals
    Disc Medicine Showcases 2026 Achievements And Business Goals

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216904/0/en/Disc-Medicine-Highlights-Recent-Achievements-and-Key-Business-Objectives-and-Milestones-for-2026.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Disc Shares Slip as FDA's Prasad Questions Bitopertin
    Disc Shares Slip as FDA's Prasad Questions Bitopertin

    22 Dec 2025

    // BIOSPACE

    https://www.biospace.com/fda/disc-shares-slip-amid-report-fdas-prasad-is-skeptical-of-bitopertins-efficacy

    BIOSPACE
    22 Dec 2025
    Share Share
    Disc Medicine Reports Q3 2025 Financial Results & Business
    Disc Medicine Reports Q3 2025 Financial Results & Business

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182593/0/en/Disc-Medicine-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Disc Medicine Updates Hematology Portfolio And Business Goals
    Disc Medicine Updates Hematology Portfolio And Business Goals

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169201/0/en/Disc-Medicine-Provides-Update-on-Hematology-Portfolio-and-Outlines-Near-Term-Business-Objectives-and-Anticipated-Milestones.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.